Primaquine Phosphate Tablet
Product Images NDC 43063-721

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Primaquine Phosphate (NDC 43063-721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063721

This is a medication label for Primaquine Phosphate USP with the strength per tablet of 26.3mg. It contains fourteen tablets and one packet of 110017 tablets. The label emphasizes the need to finish the entire medication unless advised otherwise by a doctor. It also advises users to report side effects to FDA and provides relevant contact information. The lot indicated on the label is H19E27, and the expiry date for the medications is June 2021. Other information captured includes Dosage instructions in English and Spanish, tablet composition details, and the barcode.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.